X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2024-04-02 | CERT | Smith Patrick F | Pres, DRUG DEV SOLUTIONS | S - Sale | $16.85 | -14,427 | 50,091 | -22% | -$243,161 | ||||||
2024-02-20 | CERT | Smith Patrick F | Pres, DRUG DEV SOLUTIONS | S - Sale | $18.00 | -5,000 | 54,975 | -8% | -$90,000 | ||||||
2023-06-05 | CERT | Smith Patrick F | Pres, INTEGRATED DRUG DEV | S - Sale | $21.55 | -19,104 | 59,975 | -24% | -$411,691 | ||||||
2022-11-09 | CERT | Smith Patrick F | Pres, INTEGRATED DRUG DEV | S - Sale | $13.48 | -2,387 | 74,859 | -3% | -$32,177 | ||||||
2022-08-16 | CERT | Smith Patrick F | Pres, INTEGRATED DRUG DEV | S - Sale | $17.71 | -10,000 | 78,490 | -11% | -$177,100 | ||||||
2022-06-08 | CERT | Smith Patrick F | Pres, INTEGRATED DRUG DEV | S - Sale | $19.16 | -10,000 | 88,490 | -10% | -$191,600 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |